Functional Selectivity of Hallucinogenic Phenethylamine and Phenylisopropylamine Derivatives at Human 5-Hydroxytryptamine (5-HT)2A and 5-HT2C Receptors

@article{Moya2007FunctionalSO,
  title={Functional Selectivity of Hallucinogenic Phenethylamine and Phenylisopropylamine Derivatives at Human 5-Hydroxytryptamine (5-HT)2A and 5-HT2C Receptors},
  author={Pablo R Moya and Kelly A Berg and Manuel A. Guti{\'e}rrez-Hern{\'a}ndez and Patricio Saez-Briones and Miguel Reyes-Parada and Bruce K. Cassels and William P Clarke},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2007},
  volume={321},
  pages={1054 - 1061}
}
  • P. Moya, K. Berg, +4 authors W. Clarke
  • Published 1 June 2007
  • Biology, Medicine
  • Journal of Pharmacology and Experimental Therapeutics
2,5-Dimethoxy-4-substituted phenylisopropylamines and phenethylamines are 5-hydroxytryptamine (serotonin) (5-HT)2A/2C agonists. The former are partial to full agonists, whereas the latter are partial to weak agonists. However, most data come from studies analyzing phospholipase C (PLC)-mediated responses, although additional effectors [e.g., phospholipase A2 (PLA2)] are associated with these receptors. We compared two homologous series of phenylisopropylamines and phenethylamines measuring both… 
Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives).
TLDR
The relatively high affinities of various 2C-BI derivatives at the serotonin 5-HT2A receptor indicate a high steric tolerance of the binding pocket, and suggests that these substances may potentially exert psychedelic effects similar to other compounds of the 2C family.
Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines
TLDR
4-alkyloxy-substituted 2,5-dimethoxyamphetamines and Phenethylamines share some trends with the many other phenethylamine pharmacophore containing compounds, such as when increasing the size of the 4- substituent and increasing the lipophilicity, the affinities at the 5-HT2A/C subtype also increase, and only weak 5- HT2A or C subtype selectivities were achieved.
Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)
TLDR
The receptor binding profile of 2C-T drugs predicts psychedelic effects that are mediated by potent 5-HT2 receptor interactions, and these effects are sometimes sold as new psychoactive substances (NPSs).
5-HT2 receptor binding, functional activity and selectivity in N-benzyltryptamines
TLDR
Although some N-benzyltryptamines might be abuse-liable, others might represent new leads for the development of therapeutics for weight loss, erectile dysfunction, drug abuse, or schizophrenia.
Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response
TLDR
25I-NBOMe is a highly potent derivative of 2C-I, confirming previous in vitro findings that N-benzyl substitution increases 5-HT(2A) affinity, and it is likely that the recreational use of these hallucinogens will become more widespread in the future.
Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model
TLDR
Results indicate that 5-HT2C receptor agonists and antagonists attenuate the DOI-elicited-HTR in C57Bl/6J mice, and suggest that structurally diverse 5- HT2C ligands result in different5-HT 2C receptor signaling outcomes compared to DOI.
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
TLDR
The receptor interaction profiles of the tryptamines predict hallucinogenic effects that are similar to classic serotonergic hallucinogens but also MDMA-like psychoactive properties.
The serotonin 5-HT2A receptor agonist TCB-2: a behavioral and neurophysiological analysis
TLDR
The current studies are important, as they are among the first to report the behavioral and neurophysiological effects of this conformationally restricted phenethylamine analog compound, which has 65-fold greater effects on signaling via the phosphoinositide versus arachidonic acid pathways.
Role of the 5-HT2A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice
TLDR
It is confirmed that phenylalkylamine hallucinogens increase locomotor activity in mice and demonstrated that this effect is mediated by 5-HT₂A receptor activation, and provided additional support for the link between 5- HT₁A activation and hallucinogenesis.
S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models
TLDR
In vitro and in vivo, the novel benzourea derivative, S32006 is a potent 5-HT2C receptor antagonist, and possesses antidepressant and anxiolytic properties in diverse rodent models.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 49 REFERENCES
Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors
TLDR
The present study examined and compared the binding of 17 phenylisopropylamines at human 5- HT2A, 5-HT2B, and 5-Hat2C receptors and found a significant correlation between 5-ht2B receptor affinity and human hallucinogenic potency.
Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity.
TLDR
The results suggest that these compounds (including the widely used 5- HT2 agonists DOB and DOI) are 5-HT1C/5-HT2 agents.
Differential phospholipase C activation by phenylalkylamine serotonin 5‐HT2A receptor agonists
TLDR
The hypothesis that phenylisopropylamines have higher hallucinogenic potency than their phenethylamine analogues primarily because they have higher intrinsic activities at 5‐HT2A receptors is supported.
Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists.
TLDR
These results conform with the extended ternary complex model of receptor action that postulates the existence of partly activated receptor conformation(s) (R*) in equilibrium with the ground (R) and the activated G protein-coupled (R*G) conformations.
Serotonin 5-Hydroxytryptamine2A Receptor-Coupled Phospholipase C and Phospholipase A2 Signaling Pathways Have Different Receptor Reserves
TLDR
The data support the hypothesis of agonist-directed trafficking in NIH3T3–5HT2A cells because structurally distinct ligands were able to induce preferential activation of the PLC or PLA2 signaling pathway and conclude that structurally different ligands can differentially regulate 5-HT 2A receptor signal transduction.
SB 242084, a Selective and Brain Penetrant 5-HT2C Receptor Antagonist
TLDR
The results suggest that SB 242084 is the first reported selective potent and brain penetrant 5- HT2C receptor antagonist and has anxiolytic-like activity, but does not possess either proconvulsant or hyperphagic properties which are characteristic of mutant mice lacking the 5-HT2C receptors.
Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors
TLDR
Results indicate that lisuride may possess hallucinogenic activity, although the psychopharmacological effects of l isuride appear to be different from the hallucinationsinogenic effects of LSD.
Differences in agonist-independent activity of 5-HT2A and 5-HT2C receptors revealed by heterologous expression
TLDR
Data indicate that the 5- HT2A receptor has a much lower intrinsic ability to spontaneously adopt or maintain the active receptor conformation than does the closely related 5-HT2C receptor.
Behavioral Evidence for Interactions between a Hallucinogenic Drug and Group II Metabotropic Glutamate Receptors
TLDR
The results of the present experiments raise the possibility that the psychomimetic properties of hallucinogenic drugs may be mediated in part, via increased glutamate release following activation of 5-HT2A receptors.
1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist.
TLDR
The title compound 5 and its alpha-desmethyl congener 6 appear to be the most potent of the so-called hallucinogenic amphetamine 5-HT agonists reported to date.
...
1
2
3
4
5
...